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Abstract: 
A range of novel tetramethyl- and tetraethylisoindoline nitroxides, possessing aryl linked carboxylic acids, 
amines, alcohols and phosphonic acids were prepared. Notably, the chemistry established for the aromatic 
dibromination of the tetramethylisoindolines was not easily transferred to the corresponding tetraethylisoindoline 
system. Instead, various tetraethylisoindoline analogues were accessed by the oxidation of methyl groups 
attached to the aromatic ring to give the carboxylic acids. The increased steric bulk of the tetraethyl structures 
should limit bio-reduction and these compounds may have potential as antioxidants. 
Introduction 
Nitroxides are stable free-radical species currently utilised in a variety of applications. Although the piperidine 
and pyrrolidine based nitroxides are the most commonly used, some isoindoline nitroxides possess advantages 
over these commercially available species. The fused aromatic moiety of isoindoline nitroxides provides 
structural rigidity and enhanced thermal and chemical stability in polymers.
[1,2]
 They also possess superior 
electron paramagnetic resonance (EPR) line widths
[3]
 and their structural diversity can easily be expanded by 
aromatic substitution to generate more complex structures for a range of applications.
[4-6]
  
In biological systems, nitroxides are commonly used as potent antioxidants.
[7,8]
 Their redox and radical trapping 
properties can reduce levels of oxidative stress in cellular systems caused by reactive oxygen species (ROS)
[9-13]
 
and they can also provide radio-protection towards ionising radiation.
[14-16]
 Many disease states, such as 
Alzheimer’s disease, Parkinson’s disease, cancer and aging, are implicated by increased levels of oxidative stress.  
Our group has focused on the use of isoindoline nitroxides to reduce oxidative stress on cells affected by the 
genetic disease Ataxia Telangiectasia (A-T). This disease is characterised by neurodegeneration, 
immunodeficiency and cancer predisposition, and one symptom is elevated levels of ROS.
[17]
 The full potential of 
isoindoline aminoxyls in this area has been limited somewhat by a lack of structural variation, especially with 
regards to water solubility. To date, the most effective isoindoline nitroxide for reducing radiation-induced 
oxidative stress on cells affected with A-T is 5-carboxy-1,1,3,3-tetramethylisoindolin-2-yloxyl (1) (CTMIO, 
Figure 1).
[10]
 CTMIO (1) has also been used as a successful antioxidant in an A-T mouse model where treated 
purkinje neurons of A-T mutated mice displayed increased dendritic growth.
[18]
 In cell viability assays, 5,6-
dicarboxy-1,1,3,3-tetramethylisoindolin-2-yloxyl (2) (DCTMIO, Figure 1) has given similar results to CTMIO 
(1).
[19]
  
In order to gain a more detailed insight into the antioxidant behaviour displayed by CTMIO (1) in cells affected 
with A-T and also potentially in other diseases involving oxidative stress, we desired access to new water soluble 
derivatives of CTMIO (1). Of particular interest were analogues with bulkier ethyl groups surrounding the 
nitroxide radical as these should be more resistant to bio-reduction in vivo.
[20]
 Thus, compounds 3 and 4 with one 
or two carboxylic acid groups on the aromatic ring bearing tetraethyl substitution around the nitroxide moiety 
were initially targeted. We also sought to prepare amino acid derivatives 5 and 6 which contain both carboxylic 
acid and amine groups on the aromatic ring. Herein, we report the synthesis of a range of novel isoindoline 
nitroxides possessing water solubilising functionality.  
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Figure 1. 
Results and Discussion 
To access 5-carboxy-1,1,3,3-tetraethylisoindolin-2-yloxyl (3)(CTEIO), we pursued the route previously used to 
synthesise CTMIO (1).
[21]
 Treatment of 2-benzyl-1,1,3,3,-tetraethylisoindoline (7) with bromine in the presence 
of anhydrous aluminium trichloride gave 2,5-dibromo-1,1,3,3-tetraethylisoindoline (8) in modest yield (30%) 
(Scheme 1) after purification by column chromatography to remove the benzaldehyde which results from 
oxidative cleavage of the benzyl group by bromine.
[22]
 Subsequent reduction of bromoamine 8 with hydrogen 
peroxide in the presence of sodium bicarbonate afforded 5-bromo-1,1,3,3-tetraethylisoindoline (9) in high yield 
(98%). The corresponding tetramethyl derivative could, at this stage, be separated from the benzaldehyde side-
product by acid-base extraction. However, the presence of the more organic solubilising ethyl groups in 9 did not 
allow this work-up and the removal of benzaldehyde required chromatography. Lithiation of bromoamine 9, 
reaction with carbon dioxide and subsequent oxidation with hydrogen peroxide in the presence of a tungstate 
catalyst gave the desired nitroxide 5-carboxy-1,1,3,3-tetraethylisoindolin-2-yloxyl (3) in modest yield (21%).  
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1. 
The reported synthesis of DCTMIO (2) entails double bromination of 2-benzyl-1,1,3,3-tetramethylisoindoline 
(10) to give dibromoamine 11,
[22]
 oxidation to the nitroxide,
[22]
 palladium(0) catalysed coupling of the nitroxide 
with zinc cyanide to afford dinitrile 12
[23]
 and final hydrolysis of 12 to furnish DCTMIO (2).
[24]
 Optimisation of 
this procedure for the synthesis of DCTMIO (2) was required before it could be applied to prepare 5,6-dicarboxy-
1,1,3,3-tetraethylisoindolin-2-yloxyl (4) (DCTEIO). The dibromination of 8 with bromine, aluminium trichloride 
and catalytic pyridine to give 11 was found to proceed in a significantly higher yield (91% compared to ~50% 
previously)
[22]
 when only 7 equivalents of bromine were used in chloroform rather than carbon tetrachloride 
(Scheme 2). In our hands, however, the subsequent palladium-catalysed cyanation of 11 or of the corresponding 
dibromo nitroxide was found to be highly unreliable as repetitive coupling reactions under presumably identical 
reaction conditions often gave no conversion of the starting material to the desired dicyanides 12 or 13 (yields for 
both couplings ranged from 0 to 95%).  
As an alternative, we sought to apply a recently described procedure using copper(I)iodide and n-butylimidazole 
(nBuImi) which facilitates the conversion of aryl bromides to benzonitriles in the presence of non-toxic 
potassium hexacyanoferrate.
[25]
 Initial attempts to convert the dibromo nitroxide to the desired dinitrile nitroxide 
12 under these conditions led to a complex mixture of products which may have resulted from the interaction of 
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 3
copper(I) with the nitroxide moiety. Notably, the analogous copper(I)-catalysed coupling reaction of the 
dibromoamine 11 proceeded smoothly and gave the desired dinitrile 13 in good yield (78%) following 
recrystallisation to remove an n-butylimidazole side-product (possibly a copper(I)- n-butylimidazole complex, 
which could not be removed following acid-base work-up or column chromatography). Subsequent oxidation of 
13 with m-chloroperbenzoic acid (mCPBA) provided the dinitrile nitroxide 12 in high yield (97%). Final basic 
hydrolysis of 12 with potassium hydroxide furnished the targeted DCTMIO (2) in 86% yield (Scheme 2). 
 
 
 
 
 
 
 
 
 
 
Scheme 2. 
The optimised synthesis for DCTMIO (2) could now be investigated as a route towards the preparation of the 
desired tetraethyl derivative, DCTEIO (4). Treatment of 2-benzyl-1,1,3,3-tetraethylisoindoline (7) with bromine, 
aluminium trichloride and catalytic pyridine in chloroform, followed by N-bromoamine reduction gave a complex 
mixture of products after analysis by 
1
H NMR spectroscopy and TLC. However, some of the desired 
dibrominated product 14 could be isolated from the mixture after an acid-base extraction using diethyl ether in 
21% yield (Scheme 3). Further attempts to increase the yield of 14 by varying the equivalents of bromine and/or 
aluminium trichloride used in the reaction were unsuccessful. Opening of the pyrrolidine ring may have caused 
the observed mixture of products. Application of milder brominating agents such as N-bromosuccinimide or the 
N-bromosuccinimide-bromine system led to no reaction. 
 
 
 
 
 
 
 
 
 
Scheme 3. 
Another strategy to prepare 14 involved exhaustive ethylation of an already brominated system. Rassat
[26]
 has 
previously shown that the monobromo analogue of 15 undergoes tetraethylation with EtMgBr in 25% yield. Thus, 
we prepared 4,5-dibromophthalic anhydride (16) by permanganate oxidation of 4,5-dibromo-o-xylene and 
subsequent cyclisation of the diacid using established literature procedures.
[27]
 The anhydride 16 was easily 
converted to the corresponding phthalimide 15 (Scheme 4) using benzylamine in acetic acid in good yield (70%), 
however attempted ethylation of 15 using EtMgI in toluene gave a complex mixture which contained neither the 
desired product 17 nor the starting material 15.  
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Following this reaction, it was decided that the ethyl groups must be introduced prior to bromination of the 
aromatic ring. Therefore, in order to suppress potential ring opening of the tetraethyl-substituted pyrrolidine 
moiety during the bromination process, the use of a suitable protecting group was required (the benzyl group is 
known to be cleaved by bromine before aromatic bromination occurs).
[22]
 As the final desired product is a 
nitroxide, it seemed logical to continue the synthesis with a protected nitroxide. Accordingly, 1,1,3,3-
tetraethylisoindolin-2-yloxyl (18) was prepared using literature methods via debenzylation of 7 and subsequent 
oxidation to the nitroxide.
[28]
 Reduction of 18 by hydrogenation to the corresponding hydroxylamine, followed by 
reaction with acetyl chloride in the presence of base gave the acetyl-protected nitroxide 19 (Scheme 5).
[29]
 
Treatment of 19 with bromine, aluminium trichloride and catalytic pyridine, with a prolonged reaction time of 3 
days at room temperature, led to the formation of a 1:1 mixture of the mono-brominated and the di-brominated 
derivatives 20 and 21 (by 
1
H NMR spectroscopy), which could not be separated by column chromatography. 
Raising the reaction temperature to 60 
o
C failed to increase the yield of 21 but increased product decomposition. 
The mixture of 20 and 21 was submitted to copper(I)-mediated cyano coupling, however a complex mixture was 
obtained, possibly indicating that the acetyl-protecting group is labile under these reaction conditions. A different 
approach was therefore required for the introduction of carboxyl-groups onto the aromatic ring. 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 5. 
Another route to aromatic carboxylic acids involves the oxidation of methyl groups attached to the aromatic ring. 
In our system, an aromatic ring with methyl side chains should be tolerable of the Grignard reaction required to 
introduce the four ethyl substituents. Oxidation of the methyl groups at a later stage of the synthesis should then 
afford the desired carboxylic acid groups. Hence, 4,5-dimethylphthalic anhydride (22) was prepared according to 
the literature via a Diels-Alder reaction of 2,3-dimethyl-1,3-butadiene and maleic anhydride,
[30]
 followed by 
aromatisation using bromine
[31]
 to give 22. Subsequent reaction of 22 with benzylamine gave 2-benzyl-5,6-
dimethylphthalimide (23) in an excellent yield (91%) (Scheme 6), which when treated with EtMgI in refluxing 
toluene afforded 2-benzyl-5,6-dimethyl-1,1,3,3-tetraethylisoindoline (24) in a moderate yield (50%). Reaction of 
24 with permanganate led to oxidisation of the aromatic methyl moieties as well as the benzyl CH2 group to give 
benzamide 25 (75% yield). The same product 25 was obtained when a Jones-oxidation of 24 was performed. 
Unfortunately, 25 proved to be extremely stable as attempts to hydrolyse the amide group under acidic or basic 
conditions failed to form the desired amine 26. To remove the amide group, we reduced 25 with lithium 
aluminium hydride to afford diol 27 in good yield (79%). Subsequent debenzylation and oxidation to the 
corresponding nitroxide 28 occurred in moderate yield, however attempts to oxidise the alcohol moieties with 
permanganate or Jones’ reagent to the desired DCTEIO 4 were unsuccessful. Furthermore, attempted oxidation of 
the nitroxide 29 (formed by hydrogenation and oxidation of 24, Scheme 7) gave a complex mixture of products 
under both permanganate and Jones-oxidation conditions.  
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Scheme 6. 
As the nitroxide moiety was not stable under oxidative conditions, we decided to employ an acetate protecting 
group which should be stable during the oxidation provided that it is carried out in the absence of strong acid or 
base. Reduction of nitroxide 29 to the corresponding hydroxylamine and in situ reaction with acetyl chloride 
furnished the acetyl-protected nitroxide 30 in high yield (99%) (Scheme 7). Subsequent base free permanganate 
oxidation in the presence of magnesium sulphate
[32]
 at 90 
o
C caused complete decomposition of the starting 
material 30. Decomposition could largely be avoided when the oxidation was performed at 70 °C, yet a mixture 
of the mono-oxidised and di-oxidised products 31 and 32 were obtained in yields of 12 and 63% respectively. 
Extending the reaction time along with the repeated addition of extra permanganate failed to increase the 
conversion of 31 into the di-acid 32. Fortunately, 32 could be separated by column chromatography and 
subsequent mild hydrolysis with lithium hydroxide gave the desired 5,6-dicarboxy-1,1,3,3-tetraethylisoindolin-2-
yloxyl (4) in good yield (90%).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 7. 
In an attempt to improve the yield of CTEIO (3), we employed the same route used successfully to prepare 
DCTEIO (4). Commercially available 4-methylphthalic anhydride (33) was treated with benzylamine in acetic 
acid to give 2-benzyl-4-methylphthalimide (34) in high yield (96%) (Scheme 8). Exhaustive ethylation of 
phthalimide 34 with EtMgI afforded 2-benzyl-5-methyl-1,1,3,3-tetraethylisoindoline (35) in a modest yield 
(33%). Transformation to the nitroxide 36 was achieved by cleavage of the benzyl group and oxidation with 
hydrogen peroxide and sodium tungstate in a 61% yield. Subsequent reduction with hydrogen and reaction with 
acetyl chloride gave acetate 37, which underwent permanganate oxidation to yield acid 38 in good yield (62%). 
Final acetate hydrolysis with lithium hydroxide gave CTEIO (3) in high yield (85%). The overall yield for this 
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synthetic route following tetraethylation was significantly higher (~30%, Scheme 8) than that obtained for the 
initial synthetic pathway (6%, Scheme 1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 8. 
Another functional group which imparts water solubility is a phosphonic acid. By converting the hydroxyl groups 
of 27 into better leaving groups, the introduction of phosphonate groups can be achieved. Accordingly, the 
dibromo analogue 39 was formed by reaction of the diol 27 with phosphorus tribromide in DCM (Scheme 9). 
Heating of 39 in neat triethyl phosphite gave the diphosphonate 40 in high yield (94%). Acidic hydrolysis gave 
the corresponding diphosphonic acid derivative 41 which underwent debenzylation and subsequent oxidation to 
the nitroxide to afford the desired diphosphonic acid nitroxide 42 in moderate yield (55%). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 9. 
With the targeted CTEIO (3) and DCTEIO (4) molecules in hand, we turned our attention towards the synthesis 
of the desired tetramethyl amino acid derivatives 5 and 6. Nitration of 5-bromo-1,1,3,3-tetramethylisoindoline 
(43) was achieved by treatment with nitric acid in sulfuric acid to give the bromo-nitro nitroxide 44 in moderate 
yield (56%) (Scheme 10). Initial attempts to form the desired amino acid 5 by lithiation of 44 and subsequent 
reaction with either solid or gaseous carbon dioxide were unsuccessful, giving only complex mixtures of reaction 
products. However, copper(I) catalysed cyanation of 44 afforded the cyano-nitro substituted isoindoline 45 which 
could readily be oxidised to the corresponding nitroxide 46 using m-chloroperbenzoic acid (mCPBA) in 93% 
yield. Surprisingly, conversion of the cyano moiety into a carboxylic acid group by basic hydrolysis gave a 
mixture of compounds and a significant amount of decomposition. Thus, the reverse reaction strategy was 
pursued and reduction of the nitro moiety was attempted prior to hydrolysis of the cyano group. The reduction of 
the nitro group was achieved using tin(II)dichloride dihydrate to give the amino-cyano nitroxide 47 in a moderate 
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yield of 69%. Final treatment of 47 with aqueous base led to hydrolysis of the cyano group and the targeted 5-
amino-6-carboxy-1,1,3,3-tetramethylisoindolin-2-yloxyl (5) was isolated in 80% yield. 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 10. 
In order to obtain an ethyl extended version of 5-amino-6-carboxy-1,1,3,3-tetramethylisoindolin-2-yloxyl (5), the 
bromo-nitro derivative 44 was oxidised to the nitroxide 48 (Scheme 11). Subsequent Pd-catalysed Heck coupling 
with methyl acrylate provided acrylate 49 in good (74%) yield. Reduction of both the nitro group and the double 
bond was achieved by palladium catalysed hydrogenation of 49, however the desired product 50 could not be 
isolated as it cyclised immediately to form the corresponding lactam 51, which could be isolated in a moderate 
yield of 63%. The formation of 51 was confirmed following the preparation of methoxyamine 52 by the treatment 
of lactam 51 with methyl radicals generated from dimethyl sulfoxide, ferrous ions and hydrogen peroxide. 
Unfortunately, the lactam moiety in 51 proved to be extremely stable and could not be opened to the 
corresponding amino acid derivative 6 by hydrolysis under acidic or basic conditions. In order to avoid 
lactamisation of 51, the methyl ester moiety of 49 was first hydrolysed to the corresponding acid in quantitative 
yield. However, subsequent attempted reduction of both the nitro group and the double bond by hydrogenation 
gave a crude reaction mixture which decomposed upon purification by column chromatography. Thus, the 
targeted 5-amino-6-(carboxyethyl)-1,1,3,3-tetramethylisoindolin-2-yloxyl (6) could not be accessed by this route, 
however an interesting lactam nitroxide 51 was prepared.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 11. 
Conclusion 
An improved procedure for the synthesis of DCTMIO (2) was developed in an overall yield of 59% from 2-
benzyl-1,1,3,3-tetramethylisoindoline (10). The key step involved dicyanation of the dibromoamine 11 in the 
presence of copper(I)iodide and n-butylimidazole. This route, however, was ineffective for the preparation of 
DCTEIO (4) as the initial dibromination of 2-benzyl-1,1,3,3-tetramethylisoindoline (7) was low yielding (21%), 
possibly due to opening of the pyrrolidine ring. Hence, several alternative routes to 4 were explored. Both 
tetraethylation of 2-benzyl-5,6-dibromophthalimide (15) and cyanide coupling of 2-acetoxy-5,6-dibromo-1,1,3,3-
tetraethylisoindoline (21) were unsuccessful. Similarly, oxidation of 2-benzyl-5,6-dimethyl-1,1,3,3-
tetraethylisoindoline (24) and subsequent hydrolysis of the resulting benzamide 25 with acid or base failed to 
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give the desired amine 26. The desired compound 4 could be obtained by conversion of 24 to the nitroxide, 
acetate protection of the nitroxide, oxidation of the methyl groups attached to the aromatic ring with 
permanganate and basic removal of the acetate group in an overall yield of 26% yield (from 24). CTEIO (3) 
could be prepared from 2-benzyl-1,1,3,3-tetramethylisoindoline (7) following monobromination, lithiation and 
reaction with carbon dioxide, and oxidation to the nitroxide 3 in an overall yield of 6%. This yield could be 
increased to 30% when the same route used successfully to prepare DCTEIO (4), starting from commercially 
available 4-methylphthalic anhydride (33), was employed. A diphosphonic acid nitroxide 42 was also synthesised 
from diol 27 in 4 steps, in an overall yield of 23%. The first example of an amino acid derived isoindoline 
nitroxide 5 was prepared from 5-bromo-1,1,3,3-tetramethylisoindoline (43) in 5 steps, in a 20% overall yield. The 
synthesis of the carboxyethyl-extended version 6 of the amino acid 5 was investigated but instead of obtaining 6, 
only lactam 51 could be isolated. All of the prepared nitroxides are in the process of being tested as antioxidants 
in A-T cells and results will be reported shortly. 
Experimental Section 
General methods 
All air-sensitive reactions were carried out under an atmosphere of ultra-high purity argon. Ether and toluene 
were dried by storage over sodium wire. Tetrahydrofuran (THF) was freshly distilled from sodium benzophenone 
ketal and dichloromethane (DCM) freshly distilled from calcium hydride. Triethylamine and pyridine were dried 
by storage over potassium hydroxide. Crystalline K4[Fe(CN)6] · 3H2O was ground to a fine powder and then 
dried at 80 °C at 0.5 Torr for 10 h. 2-Benzyl-1,1,3,3-tetraethylisoindoline
[33]
 (7), 2-benzyl-1,1,3,3-
tetramethylisoindoline
[34]
 (10), 4,5-dibromophthalic anhydride
[27]
 (16), 4,5-dimethylphthalic anhydride
[27,30,31]
 (22) 
and 5-bromo-1,1,3,3-tetramethylisoindoline
[22]
 (43) were prepared using established literature procedures. All 
other reagents were purchased from commercial suppliers and used without further purification. 
1
H and 
13
C NMR 
spectra were recorded on a Bruker Avance 400 spectrometer and referenced to the relevant solvent peak. Low 
and high resolution mass spectra were recorded at the Australian National University (ANU) using either a 
Micromass autospec double focusing magnetic sector mass spectrometer (EI+ spectra) or a Bruker Apex 3 fourier 
transform ion cyclotron resonance mass spectrometer with a 4.7 T magnet (ESI+ spectra). Formulations were 
calculated in the elemental analysis programs of Mass Lynx 4.0 or Micromass Opus 3.6. Fourier transform 
infrared (FTIR) spectra were recorded on a Nicolet 870 Nexus Fourier Transform Infrared Spectrometer equipped 
with a DTGS TEC detector and an ATR objective. Elemental analyses were carried out by the University of 
Queensland Microanalytical Service. Melting points were measured on a GallenKamp Variable Temperature 
Apparatus by the capillary method and are uncorrected.  
 
2,5-Dibromo-1,1,3,3-tetraethylisoindoline (8): 2-Benzyl-1,1,3,3-tetraethylisoindoline (7) (5.00 g, 15.60 mmol) 
was dissolved in DCM (50 mL) under an atmosphere of argon. The solution was cooled on ice and a solution of 
bromine (1.80 mL, 35 mmol) in DCM (38 mL) was added dropwise, followed by the immediate addition of 
aluminum trichloride (7.50 g, 56.30 mmol). The solution was stirred at 0 
o
C for 1 h and then poured onto ice (50 
mL). After 30 min of vigorous stirring, the mixture was basified with sodium hydroxide (5 M aqueous solution) 
and extracted with DCM (3 × 60 mL). The DCM layers were washed with brine (2 × 60 mL) and concentrated at 
reduced pressure to give an orange oil. Purification by column chromatography (eluent DCM/hexane 3 : 7) gave 
2,5-dibromo-1,1,3,3-tetraethylisoindoline (8) as a pale orange oil (1.90 g, 31%), containing trace amounts (<5% 
by 
1
H NMR) of 2,5,6-tribromo-1,1,3,3-tetraethylisoindoline. 
1
H NMR (400 MHz, CDCl3): δ = 0.85-0.92 (m, 12 
H, 4 × CH3), 1.6-1.79 (m, 8 H, 4 × CH2), 6.94 (d, J = 8.1 Hz, 1 H, H7), 7.2 (d, J = 1.8 Hz, 1 H, H6), 7.33 (dd, J = 
8.1, 1.8 Hz, 1 H, H4). 
13
C NMR (100 MHz, CDCl3): δ = 8.8 (CH3), 33.58 (CH2), 33.62 (CH2), 68.2 (Cquat), 68.3 
(Cquat), 120.3 (Cquat) 124.0 (CH), 125.6 (CH), 129.6 (CH), 146.5 (Cquat), 150.0 (Cquat). MS (EI): m/z (%) = 389 (40), 
387/391 (20) [M
+
]. 
 
5-Bromo-1,1,3,3-tetraethylisoindoline (9): Sodium bicarbonate (0.40 g, 4.77 mmol) was added to a solution of 
2,5-dibromo-1,1,3,3-tetraethylisoindoline (8) (1.00 g, 2.57 mmol) in methanol (10 mL). Hydrogen peroxide (30% 
aqueous solution, ~15 mL) was then added slowly until the observed effervescence ceased (ensuring that some 
sodium bicarbonate remained). The solution was acidified with hydrochloric acid (2 M aqueous solution) and 
extracted with DCM (3 × 50 mL). The DCM layers were dried (anhydrous MgSO4) and concentrated in vacuo to 
give 5-bromo-1,1,3,3-tetraethylisoindoline (9) as a pale yellow solid (0.78 g, 98%) containing trace amounts 
(<5% by 
1
H NMR) of 5,6-dibromo-1,1,3,3-tetraethylisoindoline (14). M. p. > 250 
o
C (decomp.). 
1
H NMR (400 
MHz, CDCl3): δ = 1.45 (br. s, 12 H, 4 × CH3), 2.1-2.25 (m, 4 H, 2 × CH2), 2.3-2.45 (m, 4 H, 2 × CH2), 7.02 (d, J 
= 8.06 Hz, 1 H, H7), 7.26 (d, J = 1.63 Hz, 1 H, H6), 7.49 (dd, J = 8.04, 1.63 Hz, 1 H, H4). 
13
C NMR (100 MHz, 
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CDCl3): δ = 8.76 (CH3), 8.8 (CH3), 30.73 (CH2), 30.78 (CH2), 75.9 (Cquat), 76.0 (Cquat), 122.4 (Cquat), 124.7 (CH), 
126.3 (CH), 131.7 (CH), 139.8 (Cquat), 143.1 (Cquat). MS (ES): m/z (%) = 310/312 (100) [MH
+
]. HRMS: calcd. for 
C16H25
81
Br2N [MH
+
] 312.1144; found 312.1150. HRMS: calcd. for C16H25
79
Br2N [MH
+
] 310.1170; found 
310.1163. 
 
5-Carboxy-1,1,3,3-tetraethylisoindol-2-yloxyl (3): n-Butyllithium (1.60 M in hexanes, 5.76 mL, 9.22 mmol) was 
added slowly to a solution of 5-bromo-1,1,3,3-tetraethylisoindoline (9) (1.30 g, 4.19 mmol) in dry THF (12 mL) 
at –78 °C under an atmosphere of argon. After stirring for 10 min, the solution was poured onto a slurry of 
powdered dry ice and dry THF (40 mL total). The mixture was stirred until it reached room temperature and then 
concentrated to dryness. The resulting residue was dissolved in diethyl ether (50 mL) and extracted with 
hydrochloric acid (2 M aqueous solution, 2 × 30 mL). The ether layers were dried (anhydrous MgSO4) and 
concentrated in vacuo. The resulting residue was dissolved in a mixture of methanol (20 mL), water (10 mL) and 
acetonitrile (15 mL). The solution was treated with sodium hydrogen carbonate (0.29 g, 3.40 mmol) and sodium 
tungstate dihydrate (0.13 g, 0.38 mmol), followed by the addition of hydrogen peroxide solution (30%, 2.5 mL). 
The solution was stirred at ambient temperature for 24 h, extra hydrogen peroxide solution (30%, 0.50 mL) added 
and the solution stirred for a further 72 h. The mixture was basified with sodium hydroxide (2 M aqueous 
solution) and extracted with diethyl ether (3 × 60 mL) and the ether layers discarded. The basic layers were 
acidified with hydrochloric acid (2 M aqueous solution) and extracted with diethyl ether (3 × 60 mL). The ether 
layers were dried (anhydrous MgSO4) and concentrated at reduced pressure to give a yellow oil which solidified 
upon standing (0.25 g, 21%). Recrystallisation from acetonitrile gave yellow crystals. M. p. 97-99 °C. MS (ES): 
m/z (%) = 289 (100) [(M-H)
-
]. HRMS (ES): m/z: calcd. for C17H23NO3[(M-H)
-
]: 289.1678, found 289.1679. 
C17H24NO3 (290.18): calcd. C 70.32, H 8.33, N 4.82; found: C 70.29, H 8.35, N 4.77. 
 
5,6-Dibromo-1,1,3,3-tetramethylisoindoline (11): A solution of 2-benzyl-1,1,3,3-tetramethylisoindoline (10) 
(5.31 g, 20.0 mmol, 1.00 equiv.) in CHCl3 (100 mL) was cooled to 0 °C and treated with pyridine (539 µL, 6.67 
µmol, 0.33 equiv.). Bromine (7.17 mL, 140 mmol, 7.00 equiv.) was added dropwise and the reaction mixture was 
stirred for 10 min. AlCl3 (8.00 g, 60.0 mmol, 3.00 equiv.) was added and stirring was continued for 18 h whilst 
warming to ambient temperature. The reaction mixture was carefully added to 5 M aq. NaOH-sol. (100 mL) 
cooled to 0 °C. The phases were separated and the aqueous layer was extracted with CH2Cl2 (2 × 50 mL). The 
combined organic extracts were concentrated under reduced pressure. The residue was taken up in MeOH (100 
mL) and treated with NaHCO3 (2.52 g, 30.0 mmol, 1.50 equiv.). Hydrogen peroxide (4.12 mL, 40.0 mmol, 30% 
in H2O, 2.00 equiv.) was added dropwise. The obtained reaction mixture was stirred for 5 min and then 
concentrated to ~1/3 of its volume. The mixture was cooled to 0 °C, acidified by careful addition of 2 M aq. 
H2SO4-sol. (100 mL) and extracted with Et2O (3 × 100 mL). The combined organic extracts were discarded. The 
aqueous layer was basified by careful addition of 5 M aq. NaOH-sol. (pH ~12) and extracted with Et2O (3 × 100 
mL). The combined organic extracts were dried over MgSO4 and evaporated under reduced pressure. The residue 
was purified by filtration through SiO2 (120 g, EtOAc, change to EtOAc/MeOH 10:1 when product starts to come 
off) to give 6.08 g of 11 as a pale yellow oil which solidified when kept at ambient temperature (18.3 mmol, 
91%). The spectroscopic data acquired for 11 was consistent with that previously reported in the literature.
[22]
 
 
5,6-Dicyano-1,1,3,3-tetramethylisoindoline (13): 5,6-Dibromo-1,1,3,3-tetramethylisoindoline (11) (3.33 g, 10.0 
mmol, 1.00 equiv.), K4[Fe(CN)6] (1.47 g, 4.00 mmol, 0.40 equiv.) and CuI (190 mg, 1.00 mmol, 10 mol%) were 
placed in a pressure tube (20 × 2 cm) and Ar was bubbled through the tube for 10 min. Toluene (5 mL) and n-
butylimidazole (2.63 mL, 20.0 mmol, 2.00 equiv.) were added and Ar was bubbled through the reaction mixture 
for 10 min. The tube was sealed, warmed to 160 °C and the reaction mixture was vigorously stirred at this 
temperature for 3 d. The mixture was cooled to ambient temperature, diluted with H2O (50 mL) and extracted 
with EtOAc (4 × 50 mL). The combined organic extracts were washed with brine (100 mL), dried over MgSO4 
and evaporated under reduced pressure. The residue was filtered through SiO2 (150 g, EtOAc) and concentrated 
in vacuo. The residue (consisting of product and complex-bound n-butylimidazole) was recrystallised from 
hexane/EtOAc (5 mL/5 mL) to give 1.42 g of 13 as pale brown needles (6.30 mmol, 63%). Another 343 mg of 
product was obtained by evaporation of the mother liquor and treatment of the residue with Et2O/hexane (1.5 
mL/1.5 mL) (1.52 mmol, 15%). 
1
H-NMR (CDCl3, 400 MHz): δ = 1.49 (s, 12 H, CH3), 7.55 (s, 2 H, Ar-H). 
13
C-
NMR (CDCl3, 100 MHz, add. DEPT): δ = 31.5 (+, CH3), 63.4 (Cquat, CCH3), 114.9, 115.7 (Cquat, CN, Ar-C), 
127.3 (+, Ar-C), 155.0 (Cquat, Ar-C). MS (EI): m/z (%) = 225 (<1) [M
+
], 210 (100) [M
+
–CH3], 194 (86). HRMS 
(EI): m/z: calcd. for C14H15N3[M
+
]: 225.1266, found 225.1268. C14H15N3 · 0.4H2O(232.50): calcd. C 72.32, H 
6.85, N 18.07; found: C 72.65, H 6.55, N 17.82. 
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5,6-Dicyano-1,1,3,3-tetramethylisoindolin-2-yloxyl (12): A solution of 5,6-dicyano-1,1,3,3-
tetramethylisoindoline (13) (1.76 g, 7.81 mmol, 1.00 equiv.) in CH2Cl2 (75 mL) was cooled to 0 °C and treated 
with m-chloroperbenzoic acid (2.25 g, 10.0 mmol, cont. 23% H2O, 1.28 equiv.). The reaction mixture was stirred 
at 0 °C for 1 h. The cooling bath was removed and stirring was continued for 2.5 h whilst additional CH2Cl2 (25 
mL) was gradually added to dissolve precipitating solids. The reaction mixture was washed with 5 M aq. NaOH-
sol. (3 × 50 mL) and brine (75 mL), dried over MgSO4 and evaporated under reduced pressure. The residue was 
recrystallised from MeCN to give 1.82 g of 12 as yellow needles (7.57 mmol, 97%). M. p. 242-245 °C, (Lit.,
[23]
 
243-248 
o
C). MS (EI): m/z (%) = 240 (57) [M
+
], 225 (26) [M
+
–CH3], 210 (48), 195 (100), 167 (43). HRMS (EI): 
m/z: calcd. for C14H14N3O[M
+
]: 240.1137, found 240.1138. C14H14N3O (240.28): calcd. C 69.98, H 5.87, N 17.49; 
found: C 69.82, H 5.81, N 17.46. 
 
5,6-Dicarboxy-1,1,3,3-tetramethylisoindolin-2-yloxyl (2), DCTMIO: A suspension of 5,6-dicyano-1,1,3,3-
tetramethylisoindolin-2-yloxyl (12) (1.20 g, 5.00 mmol, 1.00 equiv.) in H2O/EtOH (20 mL/4 mL) was treated 
with KOH (1.40 g, 25.0 mmol, 5.00 equiv.), warmed to 105 °C and stirred at this temperature for 20 h. The 
reaction mixture was cooled to ambient temperature and washed with Et2O (20 mL). The Et2O-layer was 
discarded. The aqueous layer was acidified with 3 M aq. HCl-sol. (pH 2) and extracted with Et2O (5 × 50 mL). 
The combined organic extracts were dried over MgSO4 and evaporated under reduced pressure. The residue was 
recrystallised from H2O/MeCN (5:1) to give 1.19 g of DCTMIO (2) as light yellow flakes (4.28 mmol, 86%). M. 
p. 238-240 °C. MS (EI): m/z (%) = 278 (5) [M
+
]. C14H16NO5 · H2O (296.30): calcd. C 56.75, H 6.12, N 4.73; 
found: C 56.83, H 6.15, N 4.94.  
 
5,6-Dibromo-1,1,3,3-tetraethylisoindoline (14): 2-Benzyl-1,1,3,3-tetraethylisoindoline (7) (1.00 g, 3.11 mmol) 
was dissolved in chloroform (16 mL) under an atmosphere of argon. The solution was cooled to 0 
o
C and treated 
with pyridine (83.00 µL, 1.03 mmol) and bromine (2.39 mL, 46.65 mmol). After stirring for 15 min, aluminium 
trichloride (2.66 g, 19.90 mmol) was added and the solution was stirred at 0 
o
C for 3 h. The reaction was warmed 
to ambient temperature for an additional hour then poured into ice/water (100 mL), basified with sodium 
hydroxide (5 M aqueous solution) and stirred for 30 min. The solution was extracted with DCM (3 × 100 mL), 
washed with brine, dried (anhydrous Na2SO4) and concentrated in vacuo. The resulting residue was dissolved in 
methanol (30 mL) and sodium hydrogen carbonate (0.10 g, 1.16 mmol) added. The solution was treated with 
hydrogen peroxide solution (30%, ~ 4 mL) until the bubbling ceased (and excess sodium hydrogen carbonate 
remained). The mixture was acidified with sulfuric acid (2 M aqueous solution) and extracted with diethyl ether 
(2 × 50 mL). The ether layers were discarded. The acid layers were then basified with sodium hydroxide (5 M 
aqueous solution) and extracted with diethyl ether (3 × 50 mL). The organic layers were washed with brine, dried 
(anhydrous Na2SO4) and concentrated at reduced pressure to give a pale yellow oil (0.26 g, 21%) containing trace 
amounts (<5% by 
1
H NMR) of 5-bromo-1,1,3,3-tetraethylisoindoline (9). 
1
H NMR (400 MHz, CDCl3): δ = 0.85 
(t, J = 7.4 Hz, 12 H, 4 × CH3), 1.5-1.75 (m, 8 H, 4 × CH2), 7.24 (s, 2 H, Ar-H). 
13
C NMR (100 MHz, CDCl3): δ = 
8.8 (CH3), 33.5 (CH2), 68.3 (Cquat), 122.5 (Cquat), 127.5 (CH), 149.0 (Cquat). MS (ES): m/z (%) = 392 (50), 390 
(100), 388 (50) [M
+
]. HRMS (EI): m/z: calcd. for C16H24
79
Br
81
BrN [M
+
]: 390.0255, found 390.0252. 
 
2-Benzyl-4,5-dibromophthalimide (15): Benzylamine (6.00 mL, 54.93 mmol) was added slowly to a slurry of 
4,5-dibromophthalic anhydride (5.00 g, 16.34 mmol) in acetic acid (26 mL). The mixture was heated to reflux for 
1 h and then poured into an ice/water mixture (80 mL). The resulting solid was collected by filtration and 
recrystallised from isopropanol to give a beige powder (4.50 g, 70%). M. p. 207-209 
o
C. 
1
H NMR (400 MHz, 
CDCl3): δ = 4.34 (s, 2 H, CH2), 7.28-7.35 (m, 3 H, Ar-H), 7.39-7.43 (m, 2 H, Ar-H), 8.10 (s, 2 H, Ar-H). 
13
C 
NMR (100 MHz, CDCl3): δ = 42.0 (CH2), 128.0 (CH), 128.5 (CH), 128.6 (CH), 128.7 (CH), 131.4 (Cquat), 131.8 
(Cquat), 135.8 (Cquat), 166.0 (C=O). MS (EI): m/z (%) = 396 (80), 394 (100), 392 (80) [M
+
]. HRMS: calcd. for 
C15H9
81
Br
79
BrNO2 [M
+
] 394.8980; found 394.8984. 
 
2-Acetoxy-1,1,3,3-tetraethylisoindoline (19): A solution of 2-benzyl-1,1,3,3-tetramethylisoindoline (10) (1.24 g, 
5.03 mmol) in dry THF (20 mL) was treated with palladium (134 mg, 1.26 mmol, 10% on charcoal) and stirred 
under a balloon of H2 for 20 min. The reaction mixture was cooled to 0 °C, Et3N (1.41 mL, 10.10 mmol) and 
acetyl chloride (0.90 mL, 12.60 mmol) added slowly and the mixture was stirred at 0 °C for 1 h. The cooling bath 
was removed and stirring was continued for an additional 1.5 h. Ar was bubbled over the mixture for 10 min. The 
reaction mixture was filtered through celite and concentrated in vacuo. The residue was taken up in EtOAc (50 
mL) and washed with water (50 mL) and brine (30 mL). The organic layer was dried over MgSO4 and evaporated 
at reduced pressure. Recrystallisation from hexane (4 mL) gave 10 as beige needles (0.95 g, 65%). M. p. 91-93 
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°C.
1
H NMR (400 MHz, CDCl3): δ = 0.81 (br. t, J = 6.7 Hz, 6 H, 2 × CH3), 0.81 (br. t, J = 7.2 Hz, 6 H, 2 × CH3), 
1.6-2.07 (m, 8 H, 4 × CH2), 2.13 (s, 3 H, CH3), 7.05-7.11 (m, 2 H, Ar-H), 7.24-7.30 (m, 2 H, Ar-H). 
13
C NMR 
(100 MHz, CDCl3): δ = 8.6 (CH3), 9.5 (CH3), 19.4 (CH3), 28.9 (CH2), 30.3 (CH2), 73.7 (Cquat), 123.6 (CH), 126.6 
(CH), 141.6 (Cquat), 170.6 (C=O). MS (EI): m/z (%) = 289 (30) [M
+
].C18H27NO2 (289.20): calcd. C 74.70, H 9.40, 
N 4.84; found: C 74.54, H 9.54, N 4.93. 
 
2-Acetoxy-5-bromo-1,1,3,3-tetraethylisoindoline (20) and 2-Acetoxy-5,6-dibromo-1,1,3,3-tetraethylisoindoline 
(21): A solution of 2-acetoxy-1,1,3,3-tetraethylisoindoline (19) (0.145 g, 0.50 mmol) in chloroform (3 mL) was 
prepared under an atmosphere of argon and treated with pyridine (2 drops). Bromine (175 µL, 3.50 mmol) was 
added and the mixture was stirred for 3 min. Aluminium chloride (233 mg, 1.75 mmol) was added and the 
mixture stirred for 1 d. Additional aluminium chloride (66.7 mg, 0.50 mmol) and chloroform (1 mL) were added 
and the mixture stirred for a further 2 d. The mixture was diluted with chloroform (2 mL) , cooled on ice and 
treated with sodium thiosulfate (10% aqueous solution, 10 mL). The phases were separated and the aqueous layer 
extracted with DCM (2 × 10 mL). The combined organic extracts were dried (MgSO4) and evaporated under 
reduced pressure. Purification by silica gel chromatography (eluent hexane/EtOAc 6:1→ 1:1) gave a brown oil 
(160 mg, 78%). Analysis by 
1
H NMR spectroscopy indicated the formation of 20 and 21 in a 1 : 1 ratio (based on 
aromatic protons). 
1
H-NMR (CDCl3, 400 MHz): δ = 0.75-1.0 (m, 4 × CH3), 1.6-2.05 (m, 4 × CH2), 2.11 (s, CH3), 
6.94 (d, J = 8.1 Hz, Ar-H for 20), 7.31 (s, Ar-H for 21), 7.20 (d, J = 1.7 Hz, Ar-H for 20), 7.39 (dd, J = 8.1, 1.8 
Hz, Ar-H for 20).  
 
2-Benzyl-5,6-dimethylphthalimide (23): A suspension of 22 (7.80 g, 44.3 mmol, 1.00 equiv.) in acetic acid (50 
mL) was treated with benzylamine (6.28 mL, 57.6 mmol, 1.30 equiv.), warmed to 120 °C and stirred at this 
temperature for 1.5 h. The mixture was poured onto an ice/H2O mixture (100 mL) and filtered. The residue was 
recrystallised from EtOH to yield 10.7 g of 24 as colourless, voluminous crystals (40.3 mmol, 91%). M. p 138–
140 °C. 
1
H-NMR (CDCl3, 400 MHz): δ = 2.41 (s, 6 H, CH3), 4.83 (s, 2 H, CH2), 7.23–7.35 (m, 3 H, Ar-H), 7.40–
7.45 (m, 2 H, Ar-H), 7.61 (s, 2 H, Ar-H). 
13
C-NMR (CDCl3, 100 MHz, add. DEPT): δ = 20.6 (+, CH3), 41.5 (–, 
CH2), 124.3, 127.7, 128.5, 128.6 (+, 7 C, Ar-C), 130.1, 136.6, 143.7 (Cquat, 5 C, Ar-C). MS (EI): m/z (%) = 265 
(100) [M
+
], 247 (78), 236 (58), 222 (67), 133 (59), 104 (67), 91 (44) [C7H7
+
], 77 (42) [C6H5
+
]. HRMS (EI): m/z: 
calcd. for C17H15NO3[M
+
]: 265.1103, found 265.1102. C17H15NO2 (265.31): calcd. C 76.96, H 5.70, N 5.28; 
found: C 76.87, H 5.56, N 5.26. 
 
2-Benzyl-5,6-dimethyl-1,1,3,3-tetraethylisoindoline (24): A solution of 23 (7.00 g, 26.38 mmol, 1.00 equiv.) in 
anhydrous toluene (62 mL) was treated with ethyl magnesium iodide [freshly prepared from ethyl iodide (12.66 
mL, 158.29 mmol) and magnesium turnings (7.70 g, 316.59 mmol) in Et2O (62 mL)]. The Et2O was distilled off 
via Dean-Stark. The reaction mixture was heated to reflux, stirred for 3 h and then concentrated to about half of 
its volume. Hexane (4 × 100 mL) was added, the mixture was filtered through Celite and washed thoroughly with 
extra hexane (100 mL). The filtrate was passed through a column of basic alumina and concentrated in vacuo to 
give 4.7 g of 24 as a colourless oil which solidified when kept at ambient temperature (13.46 mmol, 51%). M. p. 
98–100 °C. 
1
H-NMR (CDCl3, 400 MHz): δ = 0.80 (t, 12 H, 
3
J = 7.0 Hz, CH2CH3), 1.45–1.65 (m, 4 H, CH2CH3), 
1.85–2.00 (m, 4 H, CH2CH3), 2.30 (s, 6 H, CH3), 4.01 (s, 2 H, CH2), 6.84 (s, 2 H, Ar-H), 7.22–7.40 (m, 3 H, Ar-
H), 7.45–7.55 (m, 2 H, Ar-H). 
13
C-NMR (CDCl3, 101 MHz, add. DEPT): δ = 9.7 (+, CH2CH3), 20.1 (–, CH2CH3), 
30.3 (+, PhCH3), 46.8 (Cquat, CCH3), 71.1 (–, NCH2), 124.5, 127.8, 129.3, 133.7 (+, 7 C, Ar-C), 126.5, 142.3, 
142.6 (Cquat, 5 C, Ar-C). MS (EI): m/z (%) = 348 (3) [M
–
–H], 320 (100), 236 (58), 91 (47) [C7H7
+
]. HRMS (EI): 
m/z: calcd. for C25H34N[M
–
–H]: 348.2691, found 348.2690. C25H35N (349.56): calcd. C 85.90, H 10.09, N 4.01; 
found: C 85.76, H 10.36, N 4.00. 
 
2-Benzoyl-1,1,3,3-tetraethylisoindoline-5,6-dicarboxylic acid (25): A suspension of 2-benzyl-1,1,3,3-tetraethyl-
5,6-dimethylisoindoline (24) (1.50 g, 4.29 mmol) and sodium hydroxide (1.00 g, 25.00 mmol) in a mixture of 
pyridine (30 mL) and water (46 mL) was treated portionwise with solid potassium permanganate (12.00 g, 76.00 
mmol). The mixture was heated at reflux for 4 days. Ethanol (30 mL) was added, the mixture filtered and the 
obtained filtrate concentrated at reduced pressure. The resulting residue was dissolved in water (80 mL), acidified 
with hydrochloric acid (2 M aqueous solution) and extracted with diethyl ether (5 × 100 mL). The combined ether 
layers were dried (anhydrous Na2SO4) and concentrated in vacuo to give a white solid (1.35 g, 75%). M. p. 244-
246 
o
C. 
1
H NMR (400 MHz, CD3OD): δ = 0.7-1.0 (m, 12 H, 4 × CH3) 1.6-1.75 (br. s, 2 H, CH2), 1.9- 2.1 (br. s, 2 
H, CH2), 2.4-2.7 (br. s, 4H, 2 × CH2), 7.4-7.7 (m, 7 H, Ar-H). 
13
C NMR (100 MHz, d6-DMSO, 50 
o
C): δ = 9.2 
(CH3), 32.6 (br. s, CH2), 122.4 (Ar-C), 125.2 (Ar-C), 127.4 (Ar-C). 128.0 (Ar-C), 132.4 (Ar-C), 139.3 (Ar-C), 
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144.0 (Ar-C), 168.0 (C=O), 169.7 (C=O), C1 and C3 not observed. m/z (%) = 422 (100) [M
–
–H]. HRMS (EI): 
m/z: calcd. for C25H28NO5[M
–
–H]: 422.1967, found 422.1954.  
 
2-Benzyl-5,6-di(hydroxymethyl)-1,1,3,3-tetraethylisoindoline (27): 2-Benzoyl-1,1,3,3-tetraethylisoindoline-5,6-
dicarboxylic acid (25) (1.0 g, 2.36 mmol) was placed in dry diethyl ether (15 mL) and a solution of lithium 
aluminium hydride (1.0 M in diethyl ether, 21.24 mL, 21.20 mmol) was added slowly. The mixture was heated at 
reflux for 3 days, cooled and carefully diluted with water (30 mL). The resulting solution was acidified with 
hydrochloric acid (2 M aqueous solution) and extracted with chloroform (3 × 40 mL). The chloroform layers were 
washed with brine, dried (anhydrous Na2SO4) and concentrated in vacuo to give 2-benzyl-5,6-di(hydroxymethyl)-
1,1,3,3-tetraethylisoindoline (27) as an off-white solid (0.71 g, 79%). M. p. 155-158 
o
C. 
1
H NMR (400 MHz, 
CDCl3): δ = 0.77 (t, J = 7.4 Hz, 12H, 4 × CH3), 1.48-1.58 (m, 4 H, 2 × CH2), 1.87-1.95 (m, 4 H, 2 × CH2), 4.0 (s, 
2 H, CH2), 4.77 (s, 4 H, 2 × CH2), 7.04 (s, 2 H, Ar-H), 7.1-7.18 (m, 3 H, Ar-H), 7.44 (m, 2H, Ar-H). 
13
C NMR 
(100 MHz, CDCl3): δ =9.7 (CH3), 30.3 (CH2), 30.9 (CH2), 46.7 (CH2), 64.8 (CH2), 71.3 (CH), 124.8 (Cquat), 126.6 
(Cquat), 127.8 (Cquat), 129.2 (Cquat), 137.1 (Cquat), 142.1 (Cquat), 145.3 (Cquat). MS (EI): m/z (%) = 380 (5) [(M-H)
+
], 
352 (75) [(M-C2H5)
+
]. HRMS: calcd. for C25H34NO2 380.2590; found 380.2586. C25H35NO2 (381.55): calcd. C 
78.70, H 9.25, N 3.67; found: C 78.81, H 9.25, N 3.67. 
 
5,6-Di(hydroxymethyl)-1,1,3,3-tetraethylisoindolin-2-yloxyl (28): An acetic acid (15 mL) solution containing 2-
benzyl-5,6-di(hydroxymethyl)-1,1,3,3-tetraethylisoindoline (27) (0.55 g, 1.44 mmol) and palladium on charcoal 
(10%, 36 mg, 33.8 µmol, 2.5 mol%) was placed under an atmosphere of hydrogen (50 psi) in a Parr hydrogenator 
for 7 hours. The solution was filtered through celite and concentrated at reduced pressure. The residue was 
dissolved in chloroform (30 mL) and washed with sodium hydrogen carbonate (saturated aqueous solution, 2 × 
30 mL) and brine (2 × 30 mL). The organic layer was dried (anhydrous Na2SO4) and concentrated in vacuo. The 
resulting residue was dissolved in methanol (5 mL). Sodium hydrogen carbonate (0.16 g, 1.9 mmol), sodium 
tungstate dihydrate (0.07 g, 0.2 mmol) and hydrogen peroxide (30%, 1.4 mL, 12 mmol) were added and the 
solution was stirred at room temperature for 2 days. Additional sodium tungstate dihydrate (0.1 g, 0.29 mmol) 
and hydrogen peroxide (30%, 2 mL, 17.1 mmol) were added and the solution was stirred for a further 2 days. 
Water (20 mL) was added and the mixture was acidified with hydrochloric acid (2 M aqueous solution) and 
extracted with DCM (3 × 30 mL). The DCM layers were washed with brine (2 × 30 mL), dried (anhydrous 
Na2SO4) and concentrated at reduced pressure. Purification by silica gel column chromatography (eluent 70% 
EtOAc/30% hexane) gave 5,6-di(hydroxymethyl)-1,1,3,3-tetraethylisoindolin-2-yloxyl (28) as a golden oil which 
solidified upon standing (0.16 g, 61%). M. p. 114-116 °C. MS (EI): m/z (%) = 306 (15) [M
+
], 278 (100) [(M-
C2H5)
+
]. HRMS: calcd. for C18H28NO3 306.2069; found 306.2069. C18H28NO3 (306.42): calcd. C 70.55, H 9.21, N 
4.57; found: C 70.61, H 9.40, N 4.44. 
 
5,6-Dimethyl-1,1,3,3-tetraethylisondoline-2-yloxyl (29): The isoindoline derivative 24 (2.15 g, 6.15 mmol, 1.00 
equiv.) was dissolved in AcOH (25 mL). Ar was bubbled over the reaction mixture for 10 min. Palladium (328 
mg, 308 µmol, 10% on charcoal, 5 mol%) was added and Ar was again bubbled over the mixture for 10 min. The 
reaction mixture was set under an atmosphere of hydrogen and shaken at 50 psi in a Parr apparatus for 3 h. Ar 
was bubbled over the mixture for 10 min. The mixture was filtered through Celite and concentrated under 
reduced pressure. The residue was filtered through SiO2 (20 g, hexane/EtOAc 5:1) and evaporated in vacuo to 
give 5,6-dimethyl-1,1,3,3-tetraethylisoindoline. 
1
H-NMR (CDCl3, 400 MHz): δ = 0.90 (t, 12 H, 
3
J = 7.0 Hz, 
CH2CH3), 1.55–1.80 (m, 8 H, CH2CH3), 2.29 (s, 6 H, PhCH3), 6.86 (s, 2 H, Ar-H). 
13
C-NMR (CDCl3, 101 MHz): 
9.02 (CH2CH3), 20.07 (CH2CH3), 33.80 (PhCH3), 68.06 (CCH2), 123.56, 134.72, 145.26 (3 C, Ar-C). The residue 
was dissolved in MeOH (20 mL), treated with NaHCO3 (775 mg, 9.23 mmol, 1.50 equiv.), Na2WO4 · 2H2O (144 
mg, 461 µmol, 7.5 mol%) and then hydrogen peroxide (3.17 mL, 30.8 mmol, 30% in H2O, 5.00 equiv.) and the 
reaction mixture was stirred for 1 d. A second portion of NaHCO3 (775 mg, 9.23 mmol, 1.50 equiv.), Na2WO4 · 
2H2O (144 mg, 461 µmol, 7.5 mol%) and hydrogen peroxide (3.17 mL, 30.8 mmol, 30% in H2O, 5.00 equiv.) 
was added and stirring was continued for an additional 2 d. The reaction mixture was concentrated to half of its 
volume, acidified by careful addition of 2 M aq. H2SO4 sol. (20 mL) and extracted with EtOAc (3 × 20 mL). The 
combined organic layers were dried over MgSO4 and evaporated under reduced pressure. The residue was filtered 
through SiO2 (40 g, hexane/EtOAc 5:1) to give 610 mg of 29 as an orange solid (2.22 mmol, 36%). 
Recrystallisation from EtOAc yielded 29 as orange crystals. On a 2.86 mmol scale, a yield of 46% was obtained. 
M. p. 127–129 °C. MS (EI): m/z (%) = 274 (35) [M
+
], 246 (90), 230 (48), 200 (52). HRMS (EI): m/z: calcd. for 
C18H28NO[M
+
]: 274.2171, found 274.2174. C18H28NO (274.43): calcd. C 78.78, H 10.28, N 5.10; found: C 78.68, 
H 10.34, N 5.08. 
 
 13
2-Acetyloxy-5,6-dimethyl-1,1,3,3-tetraethylisoindoline (30): A solution of the nitroxide 29 (592 mg, 2.16 mmol, 
1.00 equiv.) in THF (10 mL) was treated with palladium (57.5 mg, 54.0 µmol, 10% on charcoal, 2.5 mol%) and 
stirred under an atmosphere of H2 for 15 min. The reaction mixture was cooled to 0 °C, NEt3 (602 µL, 4.32 mmol, 
2.00 equiv.) and AcCl (383 µL, 5.38 mmol) were added and the mixture was stirred at 0 °C for an 20 min. The 
cooling bath was removed and stirring was continued for an additional 1 h. Ar was bubbled over the mixture for 
10 min. The reaction mixture was filtered through celite and concentrated in vacuo. The residue was taken up in 
H2O (15 mL) and extracted with EtOAc (3 × 10 mL). The combined organic extracts were dried over MgSO4 and 
evaporated under reduced pressure. The residue was purified by column chromatography (30 g SiO2, 
hexane/EtOAc 10:1) to give 676 mg of the product 30 as a pale yellow, viscous oil which solidifies within a day 
when kept at ambient temperature (2.13 mmol, 99%). M. p. 80–82 °C. 
1
H-NMR (CDCl3, 400 MHz): δ = 0.75–
0.85 (m, 6 H, CH2CH3), 0.92–1.02 (m, 6 H, CH2CH3), 1.60–1.70, 1.70–1.80, 1.80–1.92, 1.92–2.05 (m, 8 H, 
CH2CH3), 2.13 (s, 3 H, CH3CO), 2.30 (s, 6 H, PhCH3), 6.84 (s, 2 H, Ar-H). 
13
C-NMR (CDCl3, 1001 MHz, add. 
DEPT): δ = 8.62, 9.47 (+, CH2CH3), 19.44, 20.05 20.08 (+, CH3CO, PhCH3), 28.88, 30.35 (–, CH2CH3), 63.15 
(Cquat, CCH2), 124.54 (+, Ar-C), 134.90, 139.23, (Cquat, Ar-C), 170.60 (Cquat, C=O). MS (EI): m/z (%) = 316 (44) 
[M
–
–H], 288 (94), 246 (100), 228 (72), 200 (71). HRMS (EI): m/z: calcd. for C20H30NO2[M
–
–H]: 316.2277, found 
316.2280. C20H31NO2 (317.47): calcd. C 75.67, H 9.84, N 4.41; found: C 75.59, H 10.13, N 4.38. 
 
2-Acetyloxy-5-carboxy-6-methyl-1,1,3,3-tetraethylisoindoline (31) and 2-Acetyloxy-5,6-dicarboxy-1,1,3,3-
tetraethylisoindoline (32): A solution of the dimethylaryl derivative 30 (458 mg, 1.44 mmol, 1.00 equiv.) in 
tBuOH (10 mL) was warmed to 40 °C. The mixture was treated with MgSO4 (177 mg, 720 µmol, 0.50 equiv.) 
and 0.4 M aq. KMnO4-sol. (14.4 mL, 5.76 mmol, 4.00 equiv.), warmed to 70 °C and stirred at this temperature for 
7 h. A second portion of 0.4 M aq. KMnO4-sol. (7.20 mL, 2.88 mmol, 2.00 equiv.) and tBuOH (5 mL) were 
added and the mixture was stirred at 70 °C for an additional 17 h. A third portion of 0.4 M aq. KMnO4-sol. (7.20 
mL, 2.88 mmol, 2.00 equiv.) and tBuOH (5 mL) were added and stirring was continued at 70 °C for an additional 
24 h. The reaction mixture was cooled to ambient temperature, treated with iPrOH (5 mL) and stirred overnight. 
Celite (4 g) was added, stirring was continued for 1 h and the mixture was filtered through celite. The filtrate was 
concentrated under reduced pressure to half of its volume, acidified with 3 M aq. HCl-sol. (pH 2) and extracted 
with Et2O (5 × 10 mL). The combined organic extracts were washed with brine (25 mL), dried over MgSO4 and 
evaporated under reduced pressure. The residue was purified by column chromatography (20 g SiO2, 
hexane/EtOAc/HOAc 50:50:1 → EtOAc/HOAc 100:1) to give 60.2 mg of the monomethyl monocarboxy 
derivative 31 as a beige powder (173 µmol, 12%), m. p. 145–148 °C and the dicarboxy derivative 32 which was 
further purified by recrystallisation from EtOAc/hexane to give 345 mg of 32 as a colourless powder (914 µmol, 
63%). M. p. 173–175 °C. 31: 
1
H-NMR (CDCl3, 400 MHz): δ = 0.75–0.90 (m, 6 H, CH2CH3), 0.90–1.10 (m, 6 H, 
CH2CH3), 1.65–1.85 (m, 4 H, CH2CH3), 1.85–2.15 (m, 4 H, CH2CH3), 2.14 (s, 3 H, CH3CO), 2.70 (s, 3 H, 
PhCH3), 6.98 (s, 1 H, Ar-H), 7.80 (s, 1 H, Ar-H). The signal of the CO2H proton could not be assigned. 
13
C-NMR 
(CDCl3, 100 MHz, add. DEPT): δ = 8.57 (+, CH2CH3), 9.35 (br, +, CH2CH3), 19.35, 22.50 (+, CH3CO, PhCH3), 
28.93 (br, –, CH2CH3), 30.15 (–, CH2CH3), 73.59, 73.90 (Cquat, CCH2), 126.79, 126.87 (+, Ar-C), 127.01, 139.65, 
140.17, 147.37 (Cquat, Ar-C), 170.39, 173.07 (Cquat, C=O). MS (ESI): negative mode: m/z (%) = 346 (100) [M
–
–H]. 
HRMS (ESI): m/z: calcd. for C20H28NO4[M
–
–H]: 346.20183, found 346.20108. 32: 
1
H-NMR (CD3OD, 400 
MHz): δ = 0.70–0.95 (m, 6 H, CH2CH3), 0.90–1.10 (m, 6 H, CH2CH3), 1.65–1.90 (m, 4 H, CH2CH3), 1.90–2.15 
(m, 4 H, CH2CH3), 2.13 (s, 3 H, CH3CO), 7.49 (s, 2 H, Ar-H). The signals of the CO2H protons could not be 
assigned. 
13
C-NMR (CD3OD, 100 MHz, add. DEPT): δ = 7.68, 8.31 (+, CH2CH3), 17.73 (+, CH3CO), 28.48, 
29.92 (–, CH2CH3), 73.79 (Cquat, CCH2), 123.85 (+, Ar-C), 131.74, 144.84 (Cquat, Ar-C), 169.80, 170.63 (Cquat, 
C=O). MS (ESI): negative mode: m/z (%) = 376 (100) [M
–
–H]. HRMS (ESI): m/z: calcd. for C20H26NO6[M
–
–H]: 
376.17601, found 376.17490. C20H27NO6 (377.44): calcd. C 63.65, H 7.21, N 3.71; found: C 63.38, H 7.27, N 
3.65. 
 
5,6-Dicarboxyl-1,1,3,3-tetraethylisondoline-2-yloxyl (4), DCTEIO: A suspension of the dicarboxyisoindoline 32 
(175 mg, 464 µmol, 1.00 equiv.) in H2O (2 mL) was cooled to 0 °C. LiOH (55.6 mg, 2.32 mmol, 5.00 equiv.) was 
added and the mixture was stirred for 16 h while warming up to amibient temperature. The obtained solution was 
acidified by addition of 3 M aq. HCl-sol. (pH 1) and extracted with Et2O (3 × 8 mL). The combined organic 
extracts were treated with PbO2 (27.7 mg, 116 µmol, 0.25 equiv.) and stirred for 20 min. The mixture was dried 
over MgSO4, filtered and evaporated under reduced pressure. The residue was recrystallised from H2O/MeCN 
(6:1.5) to give 139 mg of DCTEIO (4) as yellow crystals (416 µmol, 90%). M. p. 186–188 °C. MS (EI): m/z (%) 
= 333 (100) [M
–
–H]. HRMS (ESI): m/z: calcd. for C18H23NO5[M
–
–H]: 333.15762, found 333.157623. C18H24NO5 
(334.39): calcd. C 64.65, H 7.23, N 4.19; found: C 64.70, H 7.40, N 4.27. 
 14
 
2-Benzyl-5-methylphthalimide (34): Benzyl amine (10.10 mL, 92.60 mmol) was added to a solution of 4-
methylphthalic anhydride (10.00 g, 61.70 mmol) in acetic acid (50 mL). The solution was heated to reflux for 1 h 
and then poured onto ice/water (150 mL) with stirring. The white precipitate was collected by filtration and 
recrystallised from ethanol to give fluffy white crystals (14.90 g, 96%). M. p. 128-130 
o
C. 
1
H-NMR (CDCl3, 400 
MHz): δ = 2.51 (s, 3 H, CH3), 4.85 (s, 2 H, CH2), 7.25-7.36 (m, 3 H, Ar-H), 7.42-7.46 (m, 2 H, Ar-H), 7.51 (dd, J 
= 7.6, 1.1 Hz, 1 H, 6-H), 7.66 (s, 1 H, 4-H), 7.73 (d, J = 7.6 Hz, 1 H, 7-H). 
13
C-NMR (CDCl3, 100 MHz): δ = 
22.0 (CH3), 41.5 (CH2), 123.2 (Ar-C), 123.9 (Ar-C), 127.7 (Ar-C), 128.5 (Ar-C), 128.6 (Ar-C), 129.5 (Ar-C), 
132.5 (Ar-C), 134.5 (Ar-C), 136.5 (Ar-C), 145.2 (Ar-C), 168.1 (C=O), 168.2 (C=O). MS (EI): m/z (%) = 251 
(100) [M
+
]. C16H13NO2 (251.10): calcd. C 76.48, H 5.21, N 5.57; found: C 76.20, H 5.03, N 5.56. 
 
2-Benzyl-5-methyl-1,1,3,3-tetraethylisoindoline (35): A solution of 2-benzyl-5-methylphthalimide (34) (10.00 g, 
40.00 mmol, 1.00 equiv.) in anhydrous toluene (80 mL) was treated with ethyl magnesium iodide [freshly 
prepared from ethyl iodide (19.20 mL, 240.0 mmol) and magnesium turnings (11.68 g, 480.0 mmol) in Et2O (100 
mL)]. The Et2O was distilled off via Dean-Stark. The reaction mixture was heated to reflux, stirred for 3 h and 
then concentrated to about half of its volume. Hexane (4 × 130 mL) was added, the mixture was filtered through 
Celite and washed thoroughly with extra hexane (100 mL). The filtrate was passed through a column of basic 
alumina and concentrated in vacuo to give 35 as a colourless oil (4.5 g, 34%). 
1
H-NMR (CDCl3, 400 MHz): δ = 
0.78 (td, J = 7.36, 3.04 Hz, 12 H, 4 × CH3), 1.45-1.62 (m, 4 H, 2 × CH2), 1.85-1.95 (m, 4 H, 2 × CH2), 2.37 (s, 3 
H, CH3), 4.00 (s, 2 H, CH2), 6.86 (s, 1 H, 4-H), 6.94 (d, J = 7.7 Hz, 1 H, 6-H), 7.02 (d, J = 7.7 Hz, 1 H, 7-H). 
13
C-
NMR (CDCl3, 100 MHz): δ = 9.59 (CH3), 9.62 (CH3), 21.5 (CH3), 30.32 (CH2), 30.34 (CH2), 46.8 (CH2), 71.0 
(Cquat), 71.2 (Cquat), 123.1 (Ar-C), 123.9 (Ar-C), 126.47 (Ar-C), 126.48 (Ar-C), 127.7 (Ar-C), 129.2 (Ar-C), 
135.0 (Ar-C), 141.7 (Ar-C), 142.5 (Ar-C), 144.7 (Ar-C). MS (EI): m/z (%) = 336 (50) [MH
+
]. HRMS (ES): m/z: 
calcd. for C24H34N[MH
+
]: 336.2691, found 336.2690.  
 
5-Methyl-1,1,3,3-tetraethylisondoline-2-yloxyl (36): 2-Benzyl-5-methyl-1,1,3,3-tetraethylisoindoline (35) (0.05 g, 
1.49 mmol) was dissolved in AcOH (25 mL). Palladium (10% on charcoal, ~20 mg) was added and the reaction 
mixture was shaken under an atmosphere of hydrogen (50 psi in a Parr apparatus) for 3 h. The mixture was 
filtered through celite and concentrated at reduced pressure. The resulting residue was dissolved in DCM (50 mL) 
and washed with sodium hydrogen carbonate (saturated aqueous solution, 3 × 50 mL). The organic phase was 
dried (anhydrous Na2SO4) and concentrated in vacuo to give a yellow oil (0.35 g). The residue was dissolved in 
MeOH (10 mL), treated with NaHCO3 (0.13 g, 1.56 mmol) and Na2WO4 · 2H2O (52.5 mg, 168 µmol), and then 
hydrogen peroxide solution (30%, 1.15 mL, 11.22 mmol,) and stirred for 1 d. A second portion of NaHCO3 (0.13 
g, 1.56 mmol), Na2WO4 · 2H2O (52.5 mg, 168 µmol) and hydrogen peroxide solution (30%, 1.15 mL, 11.22 
mmol,) was added and stirring was continued for an additional 2 d. Water (20 mL) was added and the mixture 
extracted with DCM (3 × 20 mL). The combined organic layers were washed with sulphuric acid (2 M aqueous 
solution, 2 × 25 mL), dried (anhydrous Na2SO4) and evaporated under reduced pressure. The residue was purified 
by silica gel chromatography (eluent 100% DCM) to give 36 as an orange oil (0.24 g, 61%). MS (ES): m/z (%) = 
283 (20) [MNa
+
], 261 (2) [MH
+
]. HRMS (ES): m/z: calcd. for C17H27NO [MH
+
]: 261.2093, found 261.2091. 
C187H26NO (260.20): calcd. C 78.41, H 10.06, N 5.38; found: C 78.62, H 10.23, N 5.58. 
 
2-Acetyloxy-5-methyl-1,1,3,3-tetraethylisoindoline (37): A solution of 5-methyl-1,1,3,3-tetraethylisondoline-2-
yloxyl (36) (1.00 g, 3.84 mmol) in dry THF (20 mL) was treated with palladium (102 mg, 96.0 µmol, 10% on 
charcoal) and stirred under a balloon of H2 for 30 min. The reaction mixture was cooled to 0 °C, Et3N (1.07 mL, 
7.68 mmol) and acetyl chloride (0.68 mL, 9.60 mmol) were added and the mixture was stirred at 0 °C for 30 min. 
The cooling bath was removed and stirring was continued for an additional 1 h. Ar was bubbled over the mixture 
for 10 min. The reaction mixture was filtered through celite and concentrated in vacuo. Water (50 mL) was added 
and the mixture was extracted with EtOAc (3 × 50 mL). The combined organic extracts were dried over Na2SO4 
and evaporated at reduced pressure. The resulting residue was purified by silica gel chromatography (eluent 
DCM/hexane 1:1, sample loaded in DCM) to give 37 as a colourless oil which solidified upon standing (1.10 g, 
95%). M. p. 76-78°C. 
1
H-NMR (CDCl3, 400 MHz): δ = 0.75-0.85 (m, 6 H, 2 × CH3), 0.9-1.0 (m, 6 H, 2 × CH3), 
1.6-2.05 (m, 8 H, 4 × CH2), 2.52 (s, 3 H, CH3), 2.75 (s, 3 H, CH3), 6.87 (s, 1 H, 4-H), 6.96 (d, J = 7.7 Hz, 6-H), 
7.07 (d, J = 7.7 Hz, 7-H). 
13
C-NMR (CDCl3, 100 MHz): δ = 8.6 (CH3), 9.4 (CH3), 19.4 (CH3), 21.6 (CH3), 28.9 
(CH2), 30.3 (CH2), 73.5 (Cquat), 73.6 (Cquat), 123.4 (CH), 124.0 (CH), 127.5 (CH), 136.2 (Cquat), 138.7 (Cquat), 
141.7 (Cquat), 170.6 (C=O). MS (ES): m/z (%) = 326 (40) [MNa
+
], 304 (5) [MH
+
]. HRMS (ES): m/z: calcd. for 
 15
C19H30NO2 [MH
+
]: 304.2277, found 304.2280. C19H29NO2 (303.22): calcd. C 75.21, H 9.63, N 4.62; found: C 
74.10, H 9.69, N 4.53. 
 
2-Acetyloxy-5-carboxy-1,1,3,3-tetraethylisoindoline (38): 2-Acetyloxy-5-methyl-1,1,3,3-tetraethylisoindoline 
(37) (0.75 g, 2.47 mmol) was dissolved in tert-butanol (17 mL) and warmed to 40 
o
C. Magnesium sulphate (0.30 
g, 1.24 mmol) and potassium permanganate solution (0.4 M in water, 25 mL, 10.00 mmol) were added and the 
mixture was heated at 70 
o
C for 24 h. The solution was cooled, treated with isopropanol (10 mL) and stirred for 
16 h. The mixture was filtered through celite. The filtrate was concentrated by half, acidified with hydrochloric 
acid (2 M aqueous solution) and extracted with diethyl ether (4 × 15 mL). The organic layers were dried 
(anhydrous Na2SO4) and concentrated at reduced pressure. Purification of the resulting residue by silica gel 
chromatography (eluent DCM/EtOAc 3:2) gave 38 as a white solid. Recrystallisation from hexane/EtOAc gave 
white prisms (0.51 g, 62%). M. p. 168-170 
o
C. 
1
H-NMR (CDCl3, 400 MHz): δ = 0.81 (br. s, 6 H, 2 × CH3), 0.98 
(br. s, 6 H, 2 × CH3), 1.62-1.86 (m, 4 H, 2 × CH2), 1.88-2.1 (m, 4 H, 2 × CH2), 2.13 (s, 3 H, CH3), 7.18 (d, J = 8.0 
Hz, 1 H, 7-H), 7.82 (1 H, 4-H), 8.04 (d, J = 8.0 Hz, 1 H, 6-H). 
13
C-NMR (CDCl3, 100 MHz): δ = 8.5 (CH3), 9.3 
(CH3), 19.3 (CH3), 28.9 (CH2), 30.2 (CH2), 73.7 (CH), 74.0 (CH), 123.7 (CH), 125.4 (CH), 128.0 (Cquat), 128.9 
(CH), 142.3 (Cquat), 148.2 (Cquat), 170.3 (C=O), 172.1 (C=O). MS (ES): m/z (%) = 332 (100) [(M-H)
-
]. HRMS 
(ES): m/z: calcd. for C19H26NO4 [(M-H)
-
]: 332.1862, found 332.1870. C19H27NO4 (333.42): calcd. C 68.44, H 8.16, 
N 4.20; found: C 68.48, H 8.24, N 4.13. 
 
5-Carboxy-1,1,3,3-tetraethylisoindolin-2-yloxyl (3) from (38): 2-Acetyloxy-5-carboxy-1,1,3,3-
tetraethylisoindoline (38) (0.20 g, 0.60 mmol) was suspended in water (4 mL) and the mixture cooled on ice. 
Lithium hydroxide (71 mg, 2.99 mmol) was added, the ice-bath was removed and the mixture was stirred at room 
temperature for 16 h. The resulting yellow solution was acidified with hydrochloric acid (2 M aqueous solution) 
and extracted with diethyl ether (3 × 15 mL). The combined ether layers were treated with lead oxide (71 mg, 
0.30 mmol) and stirred for 20 min. The solution was dried (Na2SO4), filtered and concentrated in vacuo to give a 
yellow oil which solidified upon standing. Recrystallisation from acetonitrile gave yellow crystals (0.15 g, 85%) 
which displayed identical properties to that synthesised above.  
 
2-Benzyl-5,6-di(bromomethyl)-1,1,3,3-tetraethylisoindoline (39): Phosphorus tribromide (0.10 mL, 3.10 mmol) 
was added slowly to an ice-cooled solution of 2-benzyl-5,6-di(hydroxymethyl)-1,1,3,3-tetraethylisoindoline (27) 
(0.50 g, 1.31 mmol) in dry DCM (10 mL) under an argon atmosphere. The solution was stirred on ice for 1.5 h, 
diluted with water (30 mL) and extracted with chloroform (3 × 30 mL). The organic layers were washed with 
brine, dried (anhydrous Na2SO4) and concentrated at reduced pressure. Purification by silica gel chromatography 
(eluent 30% DCM/70% hexane) gave 39 as a pale yellow solid (0.32 g, 48%). M. p. 164-166 °C. 
1
H NMR (400 
MHz, CDCl3): δ = 0.72-0.8 (m, 12 H, 4 × CH3), 1.48-1.6 (m, 4 H, 2 × CH2), 1.85-1.95 (m, 4 H, 2 × CH2), 3.99 (s, 
2 H, CH2), 4.71 (s, 4 H, 2 × CH2), 7.04 (s, 2 H, Ar-H), 7.22-7.34 (m, 3 H, Ar-H), 7.41-7.46 (m, 2 H, Ar-H). 
13
C 
NMR (100 MHz, CDCl3): δ = 9.6 (CH3), 30.2 (CH2), 30.9 (CH2), 46.7 (CH2), 71.4 (Cquat), 125.0 (Ar-C), 126.1 
(Ar-C), 126.7 (Ar-C), 127.9 (Ar-C), 129.2 (Ar-C), 134.1 (Ar-C), 146.4 (Ar-C). MS (EI): m/z (%) = 478/480/476 
(85/43/43) [M
+
-C2H5]. HRMS: calcd. for C25H33
81
Br2N 480.0548; found 480.0537. 
 
2-Benzyl-5,6-bis(diethoxyphosphinylmethyl)-1,1,3,3-tetraethylisoindoline (40): A solution of 2-benzyl-5,6-
di(bromomethyl)-1,1,3,3-tetraethylisoindoline (39) (0.10 g, 0.197 mmol) in triethyl phosphite (85 µL, 0.495 
mmol) was heated at 80 
o
C for 16 h. The excess diethyl phosphite was removed by distillation. Purification of the 
resulting residue by silica gel chromatography (eluent 100% EtOAc→ 10% MeOH/90% EtOAc) gave 40 as a 
golden oil which solified upon standing (0.11 g, 94%). M. p. 81-83 
o
C. 
1
H NMR (400 MHz, CDCl3): δ = 0.76 (t, 
J = 7.3 Hz, 12 H, 4 × CH3), 1.23 (t, J = 7.1 Hz, 12 H, 4 × CH3), 1.45-1.55 (m, 4 H, 2 × CH2), 1.85-1.95 (m, 4 H, 2 
× CH2), 3.43 (d, J = 20.1 Hz, 2 H, CH2), 3.92-4.08 (m, 10 H, 5 × CH2), 6.95 (d, J = 1.9 Hz, 2 H, Ar-H), 7.2-7.34 
(m, 3 H, Ar-H), 7.42-7.46 (m, 2 H, Ar-H). 
31
P NMR (162 MHz, CDCl3): δ = 27.6. 
13
C NMR (100 MHz, CDCl3): 
δ = 9.5 (s, CH3), 16.3 (t, J = 2.8 Hz, P-O-CH2CH3), 30.3 (s, CH2), 31.3 (dd, J = 139, 1.6 Hz, P-CH2), 46.7 (s, 
CH2), 62.0 (t, J = 3.3 Hz, P-O-CH2), 71.1 (s, Cquat), 126.3 (s, Ar-C), 126.5 (s, Ar-C), 127.7 (s, Ar-C), 128.2 (s, Ar-
C), 129.2 (s, Ar-C), 142.3 (s, Ar-C), 143.8 (s, Ar-C). MS (EI): m/z (%) = 620 (2) [(M-H)
+
], 592 (100) [(M-
C2H5)
+
]. HRMS: calcd. for C33H53NO6P2 620.3270; found 620.3264. C33H53NO6P2 (621.72): calcd. C 63.75, H 
8.59, N 2.25; found: C 64.03, H 8.61, N 2.21. 
 
2-Benzyl-5,6-di(phosphonomethyl)-1,1,3,3-tetraethylisoindoline (41): A solution of 2-benzyl-5,6-
bis(diethoxyphosphinylmethyl)-1,1,3,3-tetraethylisoindoline (40) (0.115 g, 0.185 mmol) was heated to reflux in 
hydrochloric acid (6 M, 4 mL) for 16 h. The solution was concentrated in vacuo and titurated with ethyl acetate (2 
 16
× 1 mL) to give 41 as a white solid (0.1 g, 92%). M. p. 280-282 
o
C. 
1
H NMR (400 MHz, d6-DMSO): δ = 1.68 (t, 
J = 7.2 Hz, 12 H, 4 × CH3), 2.35-2.45 (m, 4 H, 2 × CH2), 2.8-2.9 (m, 4 H, 2 × CH2), 4.12 (d, J = 20.4 Hz, 2 H, 
CH2), 4.91 (s, 2 H, CH2), 7.90 (s, 2 H, Ar-H), 8.13-8.4 (m, 5 H, Ar-H). 
13
C NMR (100 MHz, d6-DMSO): δ = 9.5 
(s, CH3), 29.6 (s, CH2), 32.7 (d, J = 130 Hz, P-CH2), 46.1 (s, CH2), 70.6 (s, Cquat), 125.9 (s, Ar-C), 126.7 (s, Ar-C), 
127.9 (s, Ar-C), 129.2 (s, Ar-C), 129.8 (d, J = 9.5 Hz, Ar-C), 142.0 (s, Ar-C), 142.2 (s, Ar-C). MS (ES): m/z (%) 
= 510 (100) [MH
+
]. HRMS: calcd. for C25H38NO6P2 510.2174; found 510.2176. 
 
2-Benzyl-5,6-di(phosphonomethyl)-1,1,3,3-tetraethylisoindolin-2-yloxyl (42): 2-Benzyl-5,6-
di(phosphonomethyl)-1,1,3,3-tetraethylisoindoline (41) (85.0 mg, 0.167 mmol) was dissolved in methanol (10 
mL) and palladium on carbon (~ 20 mg) added. The solution was shaken under an atmosphere for hydrogen gas 
(50 psi) for 6 h, then filtered through celite and concentrated in vacuo. The resulting residue was dissolved in 
methanol (5 mL), treated with NaHCO3 (25 mg, 0.298 mmol), Na2WO4 · 2H2O (5 mg, 16 µmol) and then 
hydrogen peroxide (0.1 mL, 30% in H2O) and the reaction mixture was stirred for 1 d. A second portion of 
NaHCO3 (25 mg, 0.298 mmol), Na2WO4 · 2H2O (5 mg, 16 µmol) and hydrogen peroxide (0.1 mL, 30% in H2O) 
was added and stirring was continued for an additional 2 d. The reaction mixture was concentrated to half of its 
volume, acidified by careful addition of 2 M aq. H2SO4 sol. and extracted with diethyl ether (3 × 10 mL). The 
combined organic layers were dried over MgSO4 and evaporated under reduced pressure to give 3 as a white 
solid (40.0 mg, 55%). M. p. >250 
o
C (decomp.). MS (EI): m/z (%) = 433 (10) [(M-H)
-
]. HRMS: calcd. for 
C18H29NO7P2 433.1419; found 433.1437. 
 
5-Bromo-6-nitro-1,1,3,3-tetramethylisoindoline (44): 5-Bromo-1,1,3,3-tetramethylisoindoline (43) (2.01 g, 7.91 
mmol) was dissolved in conc. H2SO4 (15 mL) and cooled to 0 °C. Nitric acid (3.75 mL, 70% in H2O) was added 
and the reaction mixture was stirred at 0 °C for 1 h. The cooling bath was removed and stirring was continued for 
4 h. The reaction mixture was cooled to 0 °C, diluted by careful addition of H2O (20 mL) and basified by careful 
addition of 10 M aq. NaOH-sol. (65 mL). The reaction mixture was extracted with Et2O (1 × 75 mL, 2 × 50 mL). 
The combined organic extracts were dried over MgSO4 and evaporated under reduced pressure. The residue was 
purified by filtration through SiO2 (50 g, EtOAc) and recrystallisation from hexane/EtOAc 5:1 to give 1.32 g of 
44 as yellow crystals (4.41 mmol, 56%). M. p. 136–138 °C. 
1
H-NMR (CDCl3, 400 MHz): δ = 1.48 (s, 12 H, Me), 
1.85 (br. s, 1 H, NH), 7.44 (s, 1 H, Ar-H), 7.59 (s, 1 H, Ar-H). 
13
C-NMR (CDCl3, 100 MHz, add. DEPT): δ = 
31.5, 31.6 (+, CH3), 62.9, 63.0 (br, Cquat, CCH3), 113.27 (Cquat, Ar-C), 119.2, 128.1 (+, Ar-C), 149.8 (Cquat, 2 C, 
Ar-C). The signal of the forth quarternary Ar-C could not be assigned. MS (EI): m/z (%) = 298/300 (<1/<1) [M
+
], 
283/285 (100/99) [M
+
–CH3], 237/239 (53/52), 158 (76), 143 (46). HRMS (EI): m/z: calcd. for 
C12H15BrN2O2[M
+
]: 298.0317/300.0296, found 298.0314/300.0297, calcd. for C11H12BrN2O2[M
+
–CH3]: 
283.0082/285.0062, found 283.0086/285.0056. C12H15BrN2O2 (299.17): calcd. C 48.18, H 5.05, N 9.36; found: C 
48.29, H 4.71, N 9.28. 
 
5-Cyano-6-nitro-1,1,3,3-tetramethylisoindoline (45): A solution of 5-bromo-6-nitro-1,1,3,3-
tetramethylisoindoline (44) (1.20 g, 4.00 mmol, 1.00 equiv.), K4[Fe(CN)6] (295 mg, 800 µmol, 0.20 equiv.) and 
CuI (76.2 mg, 400 µmol, 10 mol%) was placed in a pressure tube (10 × 2 cm) and Ar was bubbled through the 
tube for 10 min. Toluene (3.00 mL, stored over Na) and nbutylimidazole (1.05 mL, 8.00 mmol, 2.00 equiv.) were 
added and Ar was bubbled through the reaction mixture for 10 min. The tube was sealed, warmed to 140 °C and 
the reaction mixture was vigorously stirred at this temperature for 2 d. The mixture was cooled to ambient 
temperature, diluted with H2O (50 mL) and extracted with EtOAc (3 × 50 mL). The combined organic extracts 
were washed with brine (100 mL), dried over MgSO4 and evaporated under reduced pressure. The residue was 
filtered through SiO2 (60 g, EtOAc) and concentrated in vacuo. The residue (consisting of product and complex-
bounded nbutylimidazole) was recrystallised from hexane/EtOAc (3:2) to give 580 mg of 45 as yellow needles 
(2.36 µmol, 59%), m. p. 158–160 °C. Another 88.5 mg of product was obtained as a beige powder by evaporation 
of the mother liquid and treatment of the residue with Et2O/hexane (1:1) (361 µmol, 9%). 
1
H-NMR (CDCl3, 400 
MHz): δ = 1.53 (s, 6 H, Me), 1.54 (s, 6 H, Me), 7.62 (s, 1 H, Ar-H), 8.06 (s, 1 H, Ar-H). The signal of the Me 
groups overlapped the signal of the NH proton. 
13
C-NMR (CDCl3, 100 MHz, add. DEPT): δ = 31.4, 31.5 (+, 
CH3), 63.2, 63.3 (br, Cquat, CCH3), 107.4, (Cquat, CN), 115.4 (Cquat, Ar-C), 115. 4, 119.4 (+, Ar-C), 148.7 (Cquat, 
Ar-C), 155.7 (Cquat, 2C, Ar-C). The signal of the forth quaternary Ar-C could not be assigned. MS (EI): m/z (%) = 
245 (2) [M
+
], 230 (100) [M
+
–CH3], 184 (73), 169 (37). HRMS (EI): m/z: calcd. for C13H15N3O2[M
+
]: 245.1164, 
found 245.1166, calcd. for C12H12N3O2[M
+
–CH3]: 230.0930, found 230.0936. C13H15N3O2 (245.28): calcd. C 
63.66, H 6.16, N 17.13; found: C 63.71, H 6.02, N 17.15. 
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5-Cyano-6-nitro-1,1,3,3-tetramethylisoindolin-2-yloxyl (46): A solution of 5-cyano-1,1,3,3-tetramethyl-6-
nitroisoindoline (45) (613 mg, 2.50 mmol, 1.00 equiv.) in CH2Cl2 (75 mL) was treated with m-chloroperbenzoic 
acid (729 g, 3.25 mmol, cont. 23% H2O, 1.20 equiv.) and stirred for 1.5 h. The reaction mixture was washed with 
2 M aq. NaOH-sol. (2 × 50 mL) and brine (50 mL), dried over MgSO4 and evaporated under reduced pressure. 
The residue was recrystallised from MeCN to give 606 mg of 46 as orange needles (2.33 mmol, 93%). M. p. 
>230 °C (decomp.). MS (EI): m/z (%) = 260 (77) [M
+
], 246 (48), 230 (62), 215 (100). HRMS (EI): m/z: calcd. for 
C13H14N3O3[M
+
]: 260.1035, found 260.1035. C13H14N3O3 (260.27): calcd. C 59.99, H 5.42, N 16.14; found: C 
60.16, H 5.31, N 16.10. 
  
5-Amino-6-cyano-1,1,3,3-tetramethylisoindolin-2-yloxyl (47): A suspension of SnCl2 · 2H2O (3.38 mg, 1.50 
mmol, 3.00 equiv.) in conc. aq. HCl-sol. (1 mL) was cooled to 0 °C. 5-Cyano-1,1,3,3-tetramethyl-6-
nitroisoindolin-2-yloxyl (46) (130 mg, 500 µmol, 1.00 equiv.) was added and the mixture was stirred at 0 °C for 
10 min. The cooling bath was removed and stirring was continued for an additional 3 h. The reaction mixture was 
cooled to 0 °C, basified by careful addition of 5 M aq. NaOH-sol. (pH 12) and extracted with CH2Cl2 (4 × 10 mL). 
The combined organic extracts were washed with brine (25 mL), dried over MgSO4 and evaporated under 
reduced pressure. The residue was purified by column chromatography (10 g SiO2, hexane/EtOAc 1:1) to give 
79.6 mg of 47 as a pale beige solid (346 µmol, 69%). M. p. 198–200 °C. A sample of analytical purity was 
obtained after recrystallisation from hexane/EtOAc. MS (EI): m/z (%) = 230 (57) [M
+
], 215 (76) [M
+
–CH3], 200 
(100), 185 (85). HRMS (EI): m/z: calcd. for C13H16N3O[M
+
]: 230.1293, found 230.1293. C13H16N3O (230.29): 
calcd. C 67.80, H 7.00, N 18.25; found: C 67.84, H 7.02, N 18.23. 
 
5-Amino-6-carboxy-1,1,3,3-tetramethylisoindolin-2-yloxyl (5): A suspension of 5-amino-6-cyano-1,1,3,3-
tetramethylisoindolin-2-yloxyl (47) (70.6 mg, 307 µmol, 1.00 equiv.) in H2O/EtOH (1 mL/0.2 mL) was treated 
with KOH (86.4 mg, 1.54 mmol, 5.00 equiv.), warmed to 105 °C and stirred at this temperature for 16 h. The 
reaction mixture was cooled to ambient temperature, diluted with H2O and washed with Et2O (5 mL). The Et2O-
layer was discarded. The aqueous layer was acidified by careful addition of 3 M aq. HCl-sol. (pH 4) and extracted 
with Et2O (4 × 5 mL). The combined organic extracts were dried over MgSO4 and evaporated under reduced 
pressure. The residue was recrystallised from H2O/MeCN (2:1) to give 54.2 mg of 5 as yellow, voluminous 
needles (217 µmol, 71%). M. p. >230 °C (decomp.). MS (EI): m/z (%) = 249 (28) [M
+
], 234 (53) [M
+
–CH3], 219 
(100), 204 (53). HRMS (EI): m/z: calcd. for C13H17N2O3[M
+
]: 249.1239, found 249.1239. C13H17N2O3 (249.29): 
calcd. C 62.64, H 6.87, N 11.24; found: C 62.77, H 6.93, N 11.07. 
 
5-Bromo-6-nitro-1,1,3,3-tetramethylisoindolin-2-yloxyl (48): A solution of 5-bromo-6-nitro-1,1,3,3-
tetramethylisoindoline (44) (598 mg, 2.00 mmol, 1.00 equiv.) in MeOH (10 mL) was treated with NaHCO3 (252 
mg, 3.00 mmol, 1.50 equiv.) and Na2WO4 · 2H2O (46.8 mg, 150 µmol, 7.5 mol%). Hydrogen peroxide (1.03 mL, 
10.0 mmol, 30% in H2O) was added and the mixture was stirred at ambient temperature for 1 d. A second portion 
of Na2WO4 · 2H2O (46.8 mg, 150 µmol, 7.5 mol%) and hydrogen peroxide (129 µL, 1.25 mmol, 30% in H2O) 
were added and the mixture was stirred for an additional 2 d. After addition of H2O (20 mL), the mixture was 
extracted with EtOAc (3 × 15 mL). The combined organic extracts were dried over MgSO4 and evaporated under 
reduced pressure. The residue was filtered through SiO2 (20 g, hexane/EtOAc 1:1 → 1:3) and then recrystallised 
from EtOAc to give 460 mg of 48 as yellow crystals (1.46 mmol, 73%), m. p. >240 °C (decomp.). C12H14BrN2O3 
(314.16): calcd. C 45.88, H 4.49, N 8.92; found: C 46.10, H 4.30, N 8.86. 
 
5-(Methoxycarbonylethenyl)-6-nitro-1,1,3,3-tetramethylisoindolin-2-yloxyl (49): 5-Bromo-6-nitro-1,1,3,3-
tetramethylisoindolin-2-yloxyl (48) (408 mg, 1.30 mmol, 1.00 equiv.), potassium carbonate (270 mg, 1.95 µmol, 
1.50 equiv.), triphenylphosphine (34.1 mg, 130 µmol, 10 mol%) and palladium acetate (14.6 mg, 65.0 µmol, 5 
mol%) were placed in a pressure tube (20 × 2 cm) and Ar was bubbled through the tube for 10 min. Methyl 
acrylate (880 µL, 9.75 mmol, 7.50 equiv.) and dry dimethyl formamide (5 mL) were added and Ar was bubbled 
through the reaction mixture for 10 min. The tube was sealed, warmed to 110 °C and the reaction mixture was 
vigorously stirred at this temperature for 3 d (TLC showed no further conversion). The mixture was cooled to 
ambient temperature, diluted with H2O (10 mL) and extracted with Et2O (4 × 10 mL). The combined organic 
extracts were dried over MgSO4 and evaporated under reduced pressure. The residue was purified by column 
chromatography (25 g SiO2, hexane/EtOAc 7:1 → 6:1 → 1:1) to give 307 mg of the product 49 as an orange 
solid (961 µmol, 74%), m. p. 190–192 °C, along with 55.5 mg of unreacted starting material 48 (177 µmol, 14%). 
MS (EI): m/z (%) = 319 (100) [M
+
], 305 (31) [M
+
–CH3], 289 (17), 258 (24), 243 (42). C16H19N2O5 (319.34): 
calcd. C 60.18, H 6.00, N 8.77; found: C 60.19, H 6.00, N 8.68. 
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1,2,3,4,6,8-Hexahydro-6,6,8,8-tetramethyl-2-oxo-7H-pyrrolo[3,4-g]quinolin-7-yloxyl (51): A solution 5-
(methoxycarbonylethenyl)-6-nitro-1,1,3,3-tetramethylisoindolin-2-yloxyl (49) (0.24 g, 0.75 mmol) and palladium 
(39.90 mg, 37.5 µmol, 10% on charcoal, 5 mol%) in methanol (35 mL) was placed under an atmosphere of 
hydrogen gas (50 psi) and shaken in a Parr hydrogenator for 6 h. The reaction mixture was flushed with N2 gas. 
Lead oxide (44.9 mg, 87.5 µmol) was added and the mixture was stirred overnight. The resulting mixture was 
filtered through celite and the filtrate concentrated at reduced pressure. The residue was purified by column 
chromatography (20 g SiO2, hexane/EtOAc 3:1 → 1:5) to give 51 as a pale beige solid (122 mg, 63%). M. p. 250-
252 
o
C. MS (EI): m/z (%) = 259 (40) [M
+
], 244 (60) [M
+
–CH3], 229 (100). C15H19N2O2 (259.32): calcd. C 69.47, 
H 7.38, N 10.80; found: C 69.29, H 7.52, N 10.61. 
 
1,2,3,4,6,8-Hexahydro-7-methoxy-6,6,8,8-tetramethyl-2-oxo-7H-pyrrolo[3,4-g]quinoline (52): Hydrogen 
peroxide solution (30%, 51.5 µL) was added dropwise to a solution of 51 (20.0 mg, 77 µmol) and iron (II) 
sulphate heptahydrate (55.6 mg, 200 µmol) in DMSO (1 mL). The resulting solution was stirred at room 
temperature for 1 h and then poured into aqueous sodium hydroxide (1 M, 5 mL). The mixture was extracted with 
diethyl ether (5 × 4 mL) and the combined organic layers dried (anhydrous MgSO4) and concentrated in vacuo. 
Purification by silica column chromatography (eluent hexane/EtOAc 1 : 1 → 1 : 2) gave 52 as a beige solid (11.7 
mg, 55%). M. p. 220-222 
o
C. 
1
H-NMR (CDCl3, 400 MHz): δ = 1.42 (br. s, 12 H, 4 × CH3), 2.64 (t, J = 7.8 Hz, 2 
H, CH2), 2.96 (t, J = 7.1 Hz, 2 H, CH2), 3.8 (s, 3 H, OCH3), 6.50 (s, 1 H, Ar-H), 6.89 (s, 1 H, Ar-H), 8.28 (br. s, 1 
H, NH). 
13
C-NMR (CDCl3, 100 MHz): δ = 25.5 (CH3), 29.7 (CH2), 30.8 (CH2), 65.4 (OCH3), 66.8 (Cquat), 67.0 
(Cquat), 108.5 (CH), 121.2 (CH), 122.9 (Cquat), 136.5 (Cquat), 140.1 (Cquat), 144.8 (Cquat), 171.6 (C=O). MS (EI): m/z 
(%) = 274 (10) [M
+
], 259 (100) [M
+
–CH3]. HRMS (ES): m/z: calcd. for C16H22N2O2 [(M-H)
-
]: 274.1681, found 
274.1682. 
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